{"id":"https://openalex.org/W2152969995","doi":"https://doi.org/10.1530/eje-09-0101","title":"Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials","display_name":"Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials","alternate_titles":[],"publication_year":2009,"publication_date":"2009-03-24","ids":{"openalex":"https://openalex.org/W2152969995","doi":"https://doi.org/10.1530/eje-09-0101","mag":"2152969995","pmid":"https://pubmed.ncbi.nlm.nih.gov/19318378"},"language":"en","primary_location":{"id":"doi:10.1530/eje-09-0101","doi":"https://doi.org/10.1530/eje-09-0101","is_oa":false,"landing_page_url":"https://doi.org/10.1530/eje-09-0101","pdf_url":null,"source":{"id":"https://openalex.org/S4210218062","display_name":"European Journal of Endocrinology","issn_l":"0804-4643","issn":["0804-4643","1479-683X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Endocrinology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2152969995"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.openaccessrepository.it/record/162322","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059413618","display_name":"Matteo Monami","orcid":"https://orcid.org/0000-0001-9349-828X","observed_orcids":["https://orcid.org/0000-0001-9349-828X"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]},{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Matteo Monami","raw_affiliation_strings":["Unit of Geriatric Medicine, Department of Critical Care Medicine, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Geriatric Medicine, Department of Critical Care Medicine, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy","institution_ids":["https://openalex.org/I4210115393","https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068485330","display_name":"Niccol\u00f2 Marchionni","orcid":"https://orcid.org/0000-0002-8101-4695","observed_orcids":["https://orcid.org/0000-0002-8101-4695"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]},{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Niccol\u00f2 Marchionni","raw_affiliation_strings":["Unit of Geriatric Medicine, Department of Critical Care Medicine, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Geriatric Medicine, Department of Critical Care Medicine, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy","institution_ids":["https://openalex.org/I4210115393","https://openalex.org/I45084792"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059685674","display_name":"Edoardo Mannucci","orcid":"https://orcid.org/0000-0001-9759-9408","observed_orcids":["https://orcid.org/0000-0001-9759-9408"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]},{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Edoardo Mannucci","raw_affiliation_strings":["Unit of Geriatric Medicine, Department of Critical Care Medicine, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Geriatric Medicine, Department of Critical Care Medicine, University of Florence and Azienda Ospedaliera Careggi, Florence, Italy","institution_ids":["https://openalex.org/I4210115393","https://openalex.org/I45084792"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5059685674"],"corresponding_institution_ids":["https://openalex.org/I4210115393","https://openalex.org/I45084792"],"apc_list":{"value":3798,"currency":"EUR","value_usd":4292},"apc_paid":null,"fwci":2.5342,"has_fulltext":false,"cited_by_count":156,"citation_normalized_percentile":{"value":0.92754614,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"160","issue":"6","first_page":"909","last_page":"917"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9229999780654907},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9779999852180481},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9900000095367432},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":1.0},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8040000200271606},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8709999918937683},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8169999718666077},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.8370000123977661},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.8360000252723694},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.4699999988079071},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.718999981880188},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.984000027179718}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.8752862215042114},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.8553683161735535},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8338417410850525},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.7380926012992859},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6621428728103638},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6511863470077515},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6205223202705383},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5901925563812256},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.581858217716217},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.568278431892395},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.48976874351501465},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.47779661417007446},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.47346940636634827},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.4560553729534149},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.41161197423934937},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3913664221763611},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.38887888193130493},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3649439811706543},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.3433866798877716},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015992","descriptor_name":"Body Mass Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1530/eje-09-0101","doi":"https://doi.org/10.1530/eje-09-0101","is_oa":false,"landing_page_url":"https://doi.org/10.1530/eje-09-0101","pdf_url":null,"source":{"id":"https://openalex.org/S4210218062","display_name":"European Journal of Endocrinology","issn_l":"0804-4643","issn":["0804-4643","1479-683X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Endocrinology","raw_type":"journal-article"},{"id":"pmid:19318378","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19318378","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of endocrinology","raw_type":"Journal Article"},{"id":"pmh:oai:flore.unifi.it:2158/606405","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2158/606405","pdf_url":null,"source":{"id":"https://openalex.org/S4306402033","display_name":"Florence Research (University of Florence)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45084792","host_organization_name":"University of Florence","host_organization_lineage":["https://openalex.org/I45084792"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:zenodo.org:162322","doi":null,"is_oa":true,"landing_page_url":"https://www.openaccessrepository.it/record/162322","pdf_url":null,"source":{"id":"https://openalex.org/S4306402478","display_name":"INFM-OAR (INFN Catania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210116497","host_organization_name":"Istituto Nazionale di Fisica Nucleare, Sezione di Catania","host_organization_lineage":["https://openalex.org/I4210116497"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.845.2410","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.845.2410","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.eje-online.org/content/early/2009/03/24/EJE-09-0101.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:zenodo.org:162322","doi":null,"is_oa":true,"landing_page_url":"https://www.openaccessrepository.it/record/162322","pdf_url":null,"source":{"id":"https://openalex.org/S4306402478","display_name":"INFM-OAR (INFN Catania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210116497","host_organization_name":"Istituto Nazionale di Fisica Nucleare, Sezione di Catania","host_organization_lineage":["https://openalex.org/I4210116497"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W100598291","https://openalex.org/W1541796658","https://openalex.org/W1600041372","https://openalex.org/W1971441597","https://openalex.org/W1976287166","https://openalex.org/W1977119153","https://openalex.org/W1981183973","https://openalex.org/W1984740259","https://openalex.org/W1986085856","https://openalex.org/W1986215651","https://openalex.org/W1998717083","https://openalex.org/W2022630168","https://openalex.org/W2023462541","https://openalex.org/W2028272916","https://openalex.org/W2035474792","https://openalex.org/W2043092889","https://openalex.org/W2050826565","https://openalex.org/W2061244748","https://openalex.org/W2071835038","https://openalex.org/W2085912144","https://openalex.org/W2098459806","https://openalex.org/W2108771199","https://openalex.org/W2110970000","https://openalex.org/W2129377335","https://openalex.org/W2133435074","https://openalex.org/W2145924144","https://openalex.org/W2146901298","https://openalex.org/W2153449155","https://openalex.org/W2159205789","https://openalex.org/W2160795579","https://openalex.org/W2162934281","https://openalex.org/W2164416879","https://openalex.org/W2170003078","https://openalex.org/W2798494090"],"related_works":["https://openalex.org/W2138897693","https://openalex.org/W2563047690","https://openalex.org/W7046057913","https://openalex.org/W2139496212","https://openalex.org/W2738794532","https://openalex.org/W2123041020","https://openalex.org/W2483597076","https://openalex.org/W4401254658","https://openalex.org/W2019660534"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1],"role":[2],"of":[3,12,79,83,115,129,135,142,193,208],"glucagon-like":[4],"peptide-1":[5],"(GLP-1)":[6],"receptor":[7,53,93,109,144,147,160,178],"agonists":[8,54,94,110,161,179],"in":[9,25,46,105,117,164,211],"the":[10,106,140,189,194],"treatment":[11],"type":[13,47],"2":[14,48],"diabetes":[15],"is":[16,132,199],"debated;":[17],"many":[18],"recent":[19],"trials,":[20],"which":[21,84,149,198],"were":[22,62],"not":[23],"included":[24,104],"previous":[26],"meta-analyses,":[27],"could":[28],"add":[29],"relevant":[30],"information.":[31],"DESIGN":[32],"AND":[33,75],"METHODS:":[34],"All":[35],"available":[36],"randomized":[37],"controlled":[38],"trials":[39],"(RCTs),":[40],"either":[41],"published":[42],"or":[43,98],"unpublished,":[44],"performed":[45],"diabetic":[49],"patients":[50,90,171],"with":[51,58,119,125,139,155,206],"GLP-1":[52,92,108,143,146,159,177],"(exenatide":[55],"and":[56,70,88,95,103,167,191],"liraglutide),":[57],"a":[59,112,126],"duration>12":[60],"weeks":[61],"meta-analysed":[63],"for":[64,201],"HbA1c,":[65],"body":[66],"mass":[67],"index,":[68],"hypoglycaemia":[69],"other":[71],"adverse":[72],"events.":[73],"RESULTS":[74],"CONCLUSIONS:":[76],"A":[77],"total":[78],"21":[80],"RCTs":[81],"(six":[82],"unpublished),":[85],"enrolling":[86],"5429":[87],"3053":[89],"(with":[91],"active":[96],"comparator":[97],"placebo":[99,120],"respectively),":[100],"was":[101],"retrieved":[102],"analysis.":[107],"determine":[111],"significant":[113],"improvement":[114],"HbA1c":[116,166],"comparison":[118],"(-1.0":[121],"(-1.1,":[122],"-0.8),":[123],"P<0.001),":[124],"low":[127],"risk":[128,138],"hypoglycaemia.":[130],"There":[131],"no":[133],"evidence":[134],"increased":[136],"cardiovascular":[137],"use":[141],"agonists.":[145],"agonists,":[148],"induce":[150],"weight":[151],"loss,":[152],"are":[153,162,180,204],"associated":[154],"gastrointestinal":[156],"side":[157],"effects.":[158],"effective":[163,182],"reducing":[165],"postprandial":[168],"glucose.":[169],"In":[170],"failing":[172],"to":[173],"sulphonylureas":[174],"and/or":[175],"metformin,":[176],"similarly":[181],"as":[183],"insulin.":[184],"Available":[185],"data":[186],"suggest":[187],"that":[188],"efficacy":[190],"tolerability":[192],"novel":[195],"agent,":[196],"liraglutide,":[197],"adequate":[200],"once-a-day":[202],"administration,":[203],"comparable":[205],"those":[207],"exenatide":[209],"bis":[210],"die.":[212]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2152969995","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":24},{"year":2012,"cited_by_count":24}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
